MC3T3-E1 cell differentiation and in vivo bone formation induced by phosphoserine

Biotechnology Letters

Volumn 33, Issue 7, 2011, Pages 1473-1480

  Park, Jin Woo ^a   Kim, Youn Jeong ^a   Jang, Je Hee ^a   An, Chang Hyeon ^a  

^a Kyungpook National University   (South Korea)

Author keywords

Bone formation; MC3T3 E1 cell; Osteoblast differentiation; Phosphoserine

Indexed keywords

ALKALINE PHOSPHATASE ACTIVITY; BONE FORMATION; CALVARIAL DEFECTS; IN-VITRO; IN-VIVO; MC3T3-E1 CELL; OSSEOUS DEFECTS; OSTEOBLAST DIFFERENTIATION; PHOSPHOSERINE;

DEFECTS; PHOSPHATASES;

BONE;

ALKALINE PHOSPHATASE; PHOSPHOSERINE;

ANIMAL; ARTICLE; BONE DEVELOPMENT; BONE MINERALIZATION; CELL DIFFERENTIATION; CELL LINE; CYTOCHEMISTRY; CYTOLOGY; DRUG EFFECT; HUMAN; METABOLISM; PHYSIOLOGY; RABBIT; SKULL; STEM CELL;

ALKALINE PHOSPHATASE; ANIMALS; CALCIFICATION, PHYSIOLOGIC; CELL DIFFERENTIATION; CELL LINE; HISTOCYTOCHEMISTRY; HUMANS; OSTEOGENESIS; PHOSPHOSERINE; RABBITS; SKULL; STEM CELLS;

ORYCTOLAGUS CUNICULUS;

EID: 79958769307     PISSN: 01415492     EISSN: 15736776     Source Type: Journal    
DOI: 10.1007/s10529-011-0565-0     Document Type: Article

References (21)

1. Aebli N, Stich H, Schawalder P, Theis JC, Krebs J (2005) Effects of bone morphogenetic protein-2 and hyaluronic acid on the osseointegration of hydroxyapatite-coated implants: an experimental study in sheep. J Biomed Mater Res A 73: 295-302.
2. Appaji Rao N, Ambili M, Jala VR, Subramanya HS, Savithri HS (2003) Structure-function relationship in serine hydroxymethyltransferase. Biochim Biophys Acta 1647: 24-29.
3. Arnander C, Westermark A, Veltheim R, Docherty-Skogh AC, Hilborn J, Engstrand T (2006) Three-dimensional technology and bone morphogenetic protein in frontal bone reconstruction. J Craniofac Surg 17: 275-279.
4. Beck GR Jr, Moran E, Knecht N (2003) Inorganic phosphate regulates multiple genes during osteoblast differentiation, including Nrf2. Exp Cell Res 288: 288-300.
5. de Koning TJ (2006) Treatment with amino acids in serine deficiency disorders. J Inherit Metab Dis 29: 347-351.
6. Ganss B, Kim RH, Sodek J (1999) Bone sialoprotein. Crit Rev Oral Biol Med 10: 79-98.
7. Itoh S, Matubara M, Kawauchi T, Nakamura H, Yukitake S, Ichinose S, Shinomiya K (2001) Enhancement of bone ingrowth in a titanium fiber mesh implant by rhBMP-2 and hyaluronic acid. J Mater Sci Mater Med 12: 575-581.
8. Knepper-Nicolai B, Reinstorf A, Hofinger I, Flade K, Wenz R, Pompe W (2002) Influence of osteocalcin and collagen I on the mechanical and biological properties of Biocement D. Biomol Eng 19: 227-231.
9. Li B, Chen X, Guo B, Wang X, Fan H, Zhang X (2009) Fabrication and cellular biocompatibility of porous carbonated biphasic calcium phosphate ceramics with a nanostructure. Acta Biomater 5: 134-143.
10. Liu Q, Ding J, Mante FK, Wunder SL, Baran GR (2002) The role of surface functional groups in calcium phosphate nucleation on titanium foil: a self-assembled monolayer technique. Biomaterials 23: 3103-3111.
11. Mai R, Lux R, Proff P, Lauer G, Pradel W, Leonhardt H, Reinstorf A, Gelinsky M, Jung R, Eckelt U, Gedrange T, Stadlinger B (2008) O-phospho-l-serine: a modulator of bone healing in calcium-phosphate cements. Biomed Tech 53: 229-233.
12. Offer L, Veigel B, Pavlidis T, Heiss C, Gelinsky M, Reistorf A, Wenisch S, Lips KS, Schnettler R (2011) Phosphoserine-modified calcium phosphate cements: bioresorption and substitution. J Tissue Eng Regen Med 5: 11-19.
13. Orimo H, Shimada T (2008) The role of tissue-nonspecific alkaline phosphatase in the phosphate-induced activation of alkaline phosphatase and mineralization in SaOS-2 human osteoblast-like cells. Mol Cell Biochem 315: 51-60.
14. Park JW, Kim YJ, Jang JH, Song H (2010a) Osteoblast response to magnesium ion-incorporated nanoporous titanium oxide surfaces. Clin Oral Implant Res 21: 1278-1287.
15. Park JW, Kim ES, Jang JH, Suh JY, Park KG, Hanawa T (2010b) Healing of rabbit calvarial bone defects using biphasic calcium phosphate ceramics made of submicron-sized grains with a hierarchical pore structure. Clin Oral Implant Res 21: 268-276.
16. Reinstorf A, Ruhnow M, Gelinsky M, Pompe W, Hempel U, Wenzel KW, Simon P (2004) Phosphoserine-a convenient compound for modification of calcium phosphate bone cement collagen composites. J Mater Sci Mater Med 15: 451-455.
17. Schaeren S, Jaquiery C, Wolf F, Papadimitropoulos A, Barbero A, Schultz-Thater E, Heberer M, Martin I (2010) Effect of bone sialoprotein coating of ceramic and synthetic polymer materials on in vitro osteogenic cell differentiation and in vivo bone formation. J Biomed Mater Res A 92: 1461-1467.
18. Schneiders W, Reinstorf A, Pompe W, Grass R, Biewener A, Holch M, Zwipp H, Rammelt S (2007) Effect of modification of hydroxyapatite/collagen composites with sodium citrate, phosphoserine, phosphoserine/RGD-peptide and calcium carbonate on bone remodelling. Bone 40: 1048-1059.
19. Sodek J, Ganss B, McKee MD (2000) Osteopontin. Crit Rev Oral Biol Med 11: 279-303.
20. Tejero R, Bierbaum S, Douglas T, Reinstorf A, Worch H, Scharnweber D (2010) Glucuronic acid and phosphoserine act as mineralization mediator of collagen I based biomimetic substrates. J Mater Sci Mater Med 21: 407-418.
21. Vater C, Lode A, Bernhardt A, Reinstorf A, Heinemann C, Gelinsky M (2010) Influence of different modifications of a calcium phosphate bone cement on adhesion, proliferation, and osteogenic differentiation of human bone marrow stromal cells. J Biomed Mater Res A 92: 1452-1460.